Investigation on the current situation of vagus nerve stimulation in the treatment of epilepsy under china's three-grade diagnosis and treatment system_Journal of Epilepsy

Authors：

YAN Raowei ¹ , ZHAO Chenyang ¹ , ZHOU Dong ¹ , ZHANG Jianguo ² , ZHANG Kai ² , WU Ye ³ , GUAN Yuguang ⁴ , SUN Jianguang ⁵ ,  WU Xintong ¹

1. Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China;
2. Department of Neurosurgery, Beijing Tiantan Hospital, Beijing 100070, China;
3. Pediatric Epilepsy Center, Peking University First Hospital, Beijing 100034, China;
4. Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China;
5. National Engineering Research Center of Neuromodulation, Tsinghua University, Beijing 100084, , China;

Corresponding author：

WU Xintong, Email: 36853839@qq.com

Keywords：

Vagus nerve stimulation; Epilepsy; Three-grade diagnosis and treatment system; Neuromodulation

DOI：

10.7507/2096-0247.202503015

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the number, distribution and characteristics of the treatment of epilepsy by vagus nerve stimulation (VNS) under China's three-grade diagnosis and treatment system from 2022 to 2023. Methods Researchers from the China Association Against Epilepsy (CAAE) conducted investigations on the number and distribution of epilepsy centers, as well as the number and distribution of VNS treatments for epilepsy from 2022 to 2023 through online and telephone surveys. Results A total of 435 epilepsy centers in China participated in the treatment of epilepsy by VNS under the three-grade system, among which 191 (43.91%) were in the eastern region. From 2022 to 2023, a total of 1 888 VNS procedures were carried out. Among them, 1 255 procedures (66.47%) were carried out in the eastern region; 1 253 procedures (66.37%) were carried out in third-level epilepsy centers, and 635 procedures (33.63%) were carried out in second-level epilepsy centers. Conclusions The promotion and application of VNS for the treatment of epilepsy under China's three-grade diagnosis and treatment system have achieved preliminary outcomes. However, there are still a regional imbalance in the VNS treatment and a shortage of abilities in primary epilepsy c enters.

Citation： YAN Raowei, ZHAO Chenyang, ZHOU Dong, ZHANG Jianguo, ZHANG Kai, WU Ye, GUAN Yuguang, SUN Jianguang, WU Xintong. Investigation on the current situation of vagus nerve stimulation in the treatment of epilepsy under china's three-grade diagnosis and treatment system. Journal of Epilepsy, 2025, 11(3): 226-230. doi: 10.7507/2096-0247.202503015 Copy

1.	Ding D, Zhou D, Sander JW, et al. Epilepsy in China: major progress in the past two decades. Lancet Neurol, 2021, 20(4): 316-326.
2.	Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000, 342(5): 314-319.
3.	Bauer S, Baier H, Baumgartner C, et al. transcutaneous vagus nerve stimulation (tvns) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02). Brain Stimul, 2016, 9(3): 356-363.
4.	Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology, 1998, 51(1): 48-55.
5.	von Wrede R, Surges R. Transcutaneous vagus nerve stimulation in the treatment of drug-resistant epilepsy. Auton Neurosci, 2021, 235: 102840.
6.	Lin Y, Hu S, Hao X, et al. Epilepsy centers in China: current status and ways forward. Epilepsia, 2021, 62(11): 2640-2650.
7.	Schiltz NK, Koroukian SM, Lhatoo SD, et al. Temporal trends in pre-surgical evaluations and epilepsy surgery in the U. S. from 1998 to 2009. Epilepsy Res, 2013, 103(2-3): 270-278.
8.	Neligan A, Haliasos N, Pettorini B, et al. A survey of adult and pediatric epilepsy surgery in the United Kingdom. Epilepsia, 2013, 54(5): e62-65.

1. Ding D, Zhou D, Sander JW, et al. Epilepsy in China: major progress in the past two decades. Lancet Neurol, 2021, 20(4): 316-326.
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000, 342(5): 314-319.
3. Bauer S, Baier H, Baumgartner C, et al. transcutaneous vagus nerve stimulation (tvns) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02). Brain Stimul, 2016, 9(3): 356-363.
4. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology, 1998, 51(1): 48-55.
5. von Wrede R, Surges R. Transcutaneous vagus nerve stimulation in the treatment of drug-resistant epilepsy. Auton Neurosci, 2021, 235: 102840.
6. Lin Y, Hu S, Hao X, et al. Epilepsy centers in China: current status and ways forward. Epilepsia, 2021, 62(11): 2640-2650.
7. Schiltz NK, Koroukian SM, Lhatoo SD, et al. Temporal trends in pre-surgical evaluations and epilepsy surgery in the U. S. from 1998 to 2009. Epilepsy Res, 2013, 103(2-3): 270-278.
8. Neligan A, Haliasos N, Pettorini B, et al. A survey of adult and pediatric epilepsy surgery in the United Kingdom. Epilepsia, 2013, 54(5): e62-65.

Previous Article
Efficacy and safety of the ketogenic diet in genetic developmental and epileptic encephalopathy
Next Article
Research progress of Lennox-Gastaut syndrome

Journal of Epilepsy

Investigation on the current situation of vagus nerve stimulation in the treatment of epilepsy under china's three-grade diagnosis and treatment system

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content